Anti-Infective Medications Market - Global Outlook and Forecast 2022-2028

March 2022 | 79 pages | ID: A5CD92039DD6EN
Market Monitor Global

Abstracts

Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.

This report contains market size and forecasts of Anti-Infective Medications in global, including the following market information:

Global Anti-Infective Medications Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Anti-Infective Medications Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Anti-Infective Medications companies in 2021 (%)

The global Anti-Infective Medications market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antivirals Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-Infective Medications include Abbott, Astellas Pharma, Bayer, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Merck, Novartis and Pfizer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Infective Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-Infective Medications Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Infective Medications Market Segment Percentages, by Type, 2021 (%)

• Antivirals
• Antibacterials
• Antifungals

Global Anti-Infective Medications Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Infective Medications Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Global Anti-Infective Medications Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Infective Medications Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-Infective Medications revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Anti-Infective Medications revenues share in global market, 2021 (%)

Key companies Anti-Infective Medications sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Anti-Infective Medications sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Astellas Pharma
• Bayer
• Bristol-Myers Squibb
• Daiichi Sankyo
• GlaxoSmithKline
• Merck
• Novartis
• Pfizer
• Roche

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-Infective Medications Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-Infective Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-INFECTIVE MEDICATIONS OVERALL MARKET SIZE

2.1 Global Anti-Infective Medications Market Size: 2021 VS 2028
2.2 Global Anti-Infective Medications Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-Infective Medications Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Anti-Infective Medications Players in Global Market
3.2 Top Global Anti-Infective Medications Companies Ranked by Revenue
3.3 Global Anti-Infective Medications Revenue by Companies
3.4 Global Anti-Infective Medications Sales by Companies
3.5 Global Anti-Infective Medications Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-Infective Medications Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-Infective Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Infective Medications Players in Global Market
  3.8.1 List of Global Tier 1 Anti-Infective Medications Companies
  3.8.2 List of Global Tier 2 and Tier 3 Anti-Infective Medications Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Anti-Infective Medications Market Size Markets, 2021 & 2028
  4.1.2 Antivirals
  4.1.3 Antibacterials
  4.1.4 Antifungals
4.2 By Type - Global Anti-Infective Medications Revenue & Forecasts
  4.2.1 By Type - Global Anti-Infective Medications Revenue, 2017-2022
  4.2.2 By Type - Global Anti-Infective Medications Revenue, 2023-2028
  4.2.3 By Type - Global Anti-Infective Medications Revenue Market Share, 2017-2028
4.3 By Type - Global Anti-Infective Medications Sales & Forecasts
  4.3.1 By Type - Global Anti-Infective Medications Sales, 2017-2022
  4.3.2 By Type - Global Anti-Infective Medications Sales, 2023-2028
  4.3.3 By Type - Global Anti-Infective Medications Sales Market Share, 2017-2028
4.4 By Type - Global Anti-Infective Medications Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-Infective Medications Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Online Pharmacies
  5.1.4 Retail Pharmacies
5.2 By Application - Global Anti-Infective Medications Revenue & Forecasts
  5.2.1 By Application - Global Anti-Infective Medications Revenue, 2017-2022
  5.2.2 By Application - Global Anti-Infective Medications Revenue, 2023-2028
  5.2.3 By Application - Global Anti-Infective Medications Revenue Market Share, 2017-2028
5.3 By Application - Global Anti-Infective Medications Sales & Forecasts
  5.3.1 By Application - Global Anti-Infective Medications Sales, 2017-2022
  5.3.2 By Application - Global Anti-Infective Medications Sales, 2023-2028
  5.3.3 By Application - Global Anti-Infective Medications Sales Market Share, 2017-2028
5.4 By Application - Global Anti-Infective Medications Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-Infective Medications Market Size, 2021 & 2028
6.2 By Region - Global Anti-Infective Medications Revenue & Forecasts
  6.2.1 By Region - Global Anti-Infective Medications Revenue, 2017-2022
  6.2.2 By Region - Global Anti-Infective Medications Revenue, 2023-2028
  6.2.3 By Region - Global Anti-Infective Medications Revenue Market Share, 2017-2028
6.3 By Region - Global Anti-Infective Medications Sales & Forecasts
  6.3.1 By Region - Global Anti-Infective Medications Sales, 2017-2022
  6.3.2 By Region - Global Anti-Infective Medications Sales, 2023-2028
  6.3.3 By Region - Global Anti-Infective Medications Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Anti-Infective Medications Revenue, 2017-2028
  6.4.2 By Country - North America Anti-Infective Medications Sales, 2017-2028
  6.4.3 US Anti-Infective Medications Market Size, 2017-2028
  6.4.4 Canada Anti-Infective Medications Market Size, 2017-2028
  6.4.5 Mexico Anti-Infective Medications Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Anti-Infective Medications Revenue, 2017-2028
  6.5.2 By Country - Europe Anti-Infective Medications Sales, 2017-2028
  6.5.3 Germany Anti-Infective Medications Market Size, 2017-2028
  6.5.4 France Anti-Infective Medications Market Size, 2017-2028
  6.5.5 U.K. Anti-Infective Medications Market Size, 2017-2028
  6.5.6 Italy Anti-Infective Medications Market Size, 2017-2028
  6.5.7 Russia Anti-Infective Medications Market Size, 2017-2028
  6.5.8 Nordic Countries Anti-Infective Medications Market Size, 2017-2028
  6.5.9 Benelux Anti-Infective Medications Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Anti-Infective Medications Revenue, 2017-2028
  6.6.2 By Region - Asia Anti-Infective Medications Sales, 2017-2028
  6.6.3 China Anti-Infective Medications Market Size, 2017-2028
  6.6.4 Japan Anti-Infective Medications Market Size, 2017-2028
  6.6.5 South Korea Anti-Infective Medications Market Size, 2017-2028
  6.6.6 Southeast Asia Anti-Infective Medications Market Size, 2017-2028
  6.6.7 India Anti-Infective Medications Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Anti-Infective Medications Revenue, 2017-2028
  6.7.2 By Country - South America Anti-Infective Medications Sales, 2017-2028
  6.7.3 Brazil Anti-Infective Medications Market Size, 2017-2028
  6.7.4 Argentina Anti-Infective Medications Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Anti-Infective Medications Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Anti-Infective Medications Sales, 2017-2028
  6.8.3 Turkey Anti-Infective Medications Market Size, 2017-2028
  6.8.4 Israel Anti-Infective Medications Market Size, 2017-2028
  6.8.5 Saudi Arabia Anti-Infective Medications Market Size, 2017-2028
  6.8.6 UAE Anti-Infective Medications Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Anti-Infective Medications Major Product Offerings
  7.1.4 Abbott Anti-Infective Medications Sales and Revenue in Global (2017-2022)
  7.1.5 Abbott Key News
7.2 Astellas Pharma
  7.2.1 Astellas Pharma Corporate Summary
  7.2.2 Astellas Pharma Business Overview
  7.2.3 Astellas Pharma Anti-Infective Medications Major Product Offerings
  7.2.4 Astellas Pharma Anti-Infective Medications Sales and Revenue in Global (2017-2022)
  7.2.5 Astellas Pharma Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Anti-Infective Medications Major Product Offerings
  7.3.4 Bayer Anti-Infective Medications Sales and Revenue in Global (2017-2022)
  7.3.5 Bayer Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Anti-Infective Medications Major Product Offerings
  7.4.4 Bristol-Myers Squibb Anti-Infective Medications Sales and Revenue in Global (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Daiichi Sankyo
  7.5.1 Daiichi Sankyo Corporate Summary
  7.5.2 Daiichi Sankyo Business Overview
  7.5.3 Daiichi Sankyo Anti-Infective Medications Major Product Offerings
  7.5.4 Daiichi Sankyo Anti-Infective Medications Sales and Revenue in Global (2017-2022)
  7.5.5 Daiichi Sankyo Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Anti-Infective Medications Major Product Offerings
  7.6.4 GlaxoSmithKline Anti-Infective Medications Sales and Revenue in Global (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Anti-Infective Medications Major Product Offerings
  7.7.4 Merck Anti-Infective Medications Sales and Revenue in Global (2017-2022)
  7.7.5 Merck Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Anti-Infective Medications Major Product Offerings
  7.8.4 Novartis Anti-Infective Medications Sales and Revenue in Global (2017-2022)
  7.8.5 Novartis Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Anti-Infective Medications Major Product Offerings
  7.9.4 Pfizer Anti-Infective Medications Sales and Revenue in Global (2017-2022)
  7.9.5 Pfizer Key News
7.10 Roche
  7.10.1 Roche Corporate Summary
  7.10.2 Roche Business Overview
  7.10.3 Roche Anti-Infective Medications Major Product Offerings
  7.10.4 Roche Anti-Infective Medications Sales and Revenue in Global (2017-2022)
  7.10.5 Roche Key News

8 GLOBAL ANTI-INFECTIVE MEDICATIONS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Anti-Infective Medications Production Capacity, 2017-2028
8.2 Anti-Infective Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Infective Medications Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTI-INFECTIVE MEDICATIONS SUPPLY CHAIN ANALYSIS

10.1 Anti-Infective Medications Industry Value Chain
10.2 Anti-Infective Medications Upstream Market
10.3 Anti-Infective Medications Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Anti-Infective Medications Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Anti-Infective Medications in Global Market
Table 2. Top Anti-Infective Medications Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Anti-Infective Medications Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Anti-Infective Medications Revenue Share by Companies, 2017-2022
Table 5. Global Anti-Infective Medications Sales by Companies, (K Units), 2017-2022
Table 6. Global Anti-Infective Medications Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Anti-Infective Medications Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Anti-Infective Medications Product Type
Table 9. List of Global Tier 1 Anti-Infective Medications Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Infective Medications Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-Infective Medications Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Anti-Infective Medications Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Anti-Infective Medications Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Anti-Infective Medications Sales (K Units), 2017-2022
Table 15. By Type - Global Anti-Infective Medications Sales (K Units), 2023-2028
Table 16. By Application – Global Anti-Infective Medications Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Anti-Infective Medications Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Anti-Infective Medications Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Anti-Infective Medications Sales (K Units), 2017-2022
Table 20. By Application - Global Anti-Infective Medications Sales (K Units), 2023-2028
Table 21. By Region – Global Anti-Infective Medications Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Anti-Infective Medications Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Anti-Infective Medications Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Anti-Infective Medications Sales (K Units), 2017-2022
Table 25. By Region - Global Anti-Infective Medications Sales (K Units), 2023-2028
Table 26. By Country - North America Anti-Infective Medications Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Anti-Infective Medications Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Anti-Infective Medications Sales, (K Units), 2017-2022
Table 29. By Country - North America Anti-Infective Medications Sales, (K Units), 2023-2028
Table 30. By Country - Europe Anti-Infective Medications Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Anti-Infective Medications Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Anti-Infective Medications Sales, (K Units), 2017-2022
Table 33. By Country - Europe Anti-Infective Medications Sales, (K Units), 2023-2028
Table 34. By Region - Asia Anti-Infective Medications Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Anti-Infective Medications Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Anti-Infective Medications Sales, (K Units), 2017-2022
Table 37. By Region - Asia Anti-Infective Medications Sales, (K Units), 2023-2028
Table 38. By Country - South America Anti-Infective Medications Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Anti-Infective Medications Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Anti-Infective Medications Sales, (K Units), 2017-2022
Table 41. By Country - South America Anti-Infective Medications Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Anti-Infective Medications Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Anti-Infective Medications Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Anti-Infective Medications Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Anti-Infective Medications Sales, (K Units), 2023-2028
Table 46. Abbott Corporate Summary
Table 47. Abbott Anti-Infective Medications Product Offerings
Table 48. Abbott Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Astellas Pharma Corporate Summary
Table 50. Astellas Pharma Anti-Infective Medications Product Offerings
Table 51. Astellas Pharma Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Bayer Corporate Summary
Table 53. Bayer Anti-Infective Medications Product Offerings
Table 54. Bayer Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Bristol-Myers Squibb Corporate Summary
Table 56. Bristol-Myers Squibb Anti-Infective Medications Product Offerings
Table 57. Bristol-Myers Squibb Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Daiichi Sankyo Corporate Summary
Table 59. Daiichi Sankyo Anti-Infective Medications Product Offerings
Table 60. Daiichi Sankyo Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. GlaxoSmithKline Corporate Summary
Table 62. GlaxoSmithKline Anti-Infective Medications Product Offerings
Table 63. GlaxoSmithKline Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Merck Corporate Summary
Table 65. Merck Anti-Infective Medications Product Offerings
Table 66. Merck Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Anti-Infective Medications Product Offerings
Table 69. Novartis Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Pfizer Corporate Summary
Table 71. Pfizer Anti-Infective Medications Product Offerings
Table 72. Pfizer Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Roche Corporate Summary
Table 74. Roche Anti-Infective Medications Product Offerings
Table 75. Roche Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Anti-Infective Medications Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Anti-Infective Medications Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Anti-Infective Medications Production by Region, 2017-2022 (K Units)
Table 79. Global Anti-Infective Medications Production by Region, 2023-2028 (K Units)
Table 80. Anti-Infective Medications Market Opportunities & Trends in Global Market
Table 81. Anti-Infective Medications Market Drivers in Global Market
Table 82. Anti-Infective Medications Market Restraints in Global Market
Table 83. Anti-Infective Medications Raw Materials
Table 84. Anti-Infective Medications Raw Materials Suppliers in Global Market
Table 85. Typical Anti-Infective Medications Downstream
Table 86. Anti-Infective Medications Downstream Clients in Global Market
Table 87. Anti-Infective Medications Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Anti-Infective Medications Segment by Type
Figure 2. Anti-Infective Medications Segment by Application
Figure 3. Global Anti-Infective Medications Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-Infective Medications Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-Infective Medications Revenue, 2017-2028 (US$, Mn)
Figure 7. Anti-Infective Medications Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Infective Medications Revenue in 2021
Figure 9. By Type - Global Anti-Infective Medications Sales Market Share, 2017-2028
Figure 10. By Type - Global Anti-Infective Medications Revenue Market Share, 2017-2028
Figure 11. By Type - Global Anti-Infective Medications Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Anti-Infective Medications Sales Market Share, 2017-2028
Figure 13. By Application - Global Anti-Infective Medications Revenue Market Share, 2017-2028
Figure 14. By Application - Global Anti-Infective Medications Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Anti-Infective Medications Sales Market Share, 2017-2028
Figure 16. By Region - Global Anti-Infective Medications Revenue Market Share, 2017-2028
Figure 17. By Country - North America Anti-Infective Medications Revenue Market Share, 2017-2028
Figure 18. By Country - North America Anti-Infective Medications Sales Market Share, 2017-2028
Figure 19. US Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Anti-Infective Medications Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Anti-Infective Medications Sales Market Share, 2017-2028
Figure 24. Germany Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 25. France Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Anti-Infective Medications Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Anti-Infective Medications Sales Market Share, 2017-2028
Figure 33. China Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 37. India Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Anti-Infective Medications Revenue Market Share, 2017-2028
Figure 39. By Country - South America Anti-Infective Medications Sales Market Share, 2017-2028
Figure 40. Brazil Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Anti-Infective Medications Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Anti-Infective Medications Sales Market Share, 2017-2028
Figure 44. Turkey Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Anti-Infective Medications Revenue, (US$, Mn), 2017-2028
Figure 48. Global Anti-Infective Medications Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Anti-Infective Medications by Region, 2021 VS 2028
Figure 50. Anti-Infective Medications Industry Value Chain
Figure 51. Marketing Channels